Randomized, Modified, Double-Blind, Placebo-Controlled, Phase II, Dose-Ranging Study of the Safety and Immunogenicity of Single Dose ChimeriVax-WN02 Vaccine in Healthy Adults
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2015
At a glance
- Drugs West Nile virus vaccine (Primary)
- Indications West Nile virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors sanofi pasteur
- 15 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2011 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 04 Dec 2009 Planned end date changed from 1 Feb 2013 to 1 Feb 2011 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History